T1	intervention 12 24	HER2 testing
T2	location 427 438	Connecticut
T3	intervention 462 484	Black/African American
T4	intervention-participants 501 504	644
T5	control-participants 532 535	720
T6	control 540 545	White
T9	outcome 886 892	tested
T10	iv-bin-percent 927 932	69.5%
T11	cv-bin-percent 937 942	61.9%
T7	outcome 1220 1229	ER status
T12	outcome 1250 1261	tumor grade
T13	outcome 1281 1291	tumor size
T14	outcome 1315 1332	lymph node status
T15	eligibility 546 613	women diagnosed in 2000-2003 with primary invasive breast carcinoma
